This medication is a synthetic (man-made) anti-viral and antiparkinson ... prescribed for Parkinson’s disease either alone or with other medications.

As officials put the change in draft rules for 2026, the incoming president's Medicare agency pick might support it.

Parkinson's drug, entacapone, induces iron deficiency, which alters the gut microbiome and triggers the growth of bacteria ...

They announced the development of a holy grail drug that switches off a ... Alzheimer's and Parkinson's. 'Our aim is that one day, anti-IL-11 therapy will be used as widely as possible, so that ...

The drugs work by helping the brain transmit messages to nerves that control movement Nearly 1,000 people with advanced Parkinson's disease are to benefit from a new treatment that involves ...

In a groundbreaking new study scientists have revealed that the widely prescribed Parkinson's disease drug entacapone significantly disrupts the human gut microbiome by inducing iron deficiency. The ...

A new study has revealed that the widely prescribed Parkinson's disease drug entacapone significantly disrupts the human gut microbiome by inducing iron deficiency. The research was conducted ...

have revealed that the widely prescribed Parkinson's disease drug entacapone significantly disrupts the human gut microbiome by inducing iron deficiency. The study, published in Nature ...

A large case-control study suggests that calcium channel blockers are the only antihypertensives that reduce the risk for Parkinson disease ... of antihypertensive drugs: angiotensin-converting ...

Parkinson's drug linked to harmful gut microbiome changes, potentially caused by iron deficiency, may worsen gut health and impact treatment outcomes. A new study reveals a surprising side effect ...

The charity Parkinson’s UK has struck a £1 million partnership with NRG Therapeutics to develop drugs targeted at mitochondria that could protect cells producing dopamine, which have been ...